» Authors » Stephen Johnston

Stephen Johnston

Explore the profile of Stephen Johnston including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 134
Citations 4234
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Acha F, Scheff T, Diaz Armas N, Mead J, Johnston S, Zhang J
Materials (Basel) . 2025 Jan; 18(2. PMID: 39859735
Epoxy nanocomposites are widely used in various applications because of their excellent properties. Different types of manufacturing techniques are used to produce epoxy composites based on various fillers, molecular weight,...
2.
Chuang F, Arasu R, Quail G, Johnston S
Aust J Gen Pract . 2024 Dec; 53(12 Suppl):S33-S40. PMID: 39693748
Background: Dysphagia, characterised by a difficulty in swallowing, stems from various causes and is frequently encountered in general practice. The rise in dysphagia in Australia's ageing population necessitates proper management...
3.
Du M, Johnston S, Coplan P, Strauss V, Khalid S, Prieto-Alhambra D
BMC Med Res Methodol . 2024 Nov; 24(1):289. PMID: 39578744
Background: Rapid innovation and new regulations lead to an increased need for post-marketing surveillance of implantable devices. However, complex multi-level confounding related not only to patient-level but also to surgeon...
4.
Phillips E, Sethi M, Vasanthakumar S, Sherpa G, Johnston S, Parton M, et al.
Cancers (Basel) . 2024 Aug; 16(16). PMID: 39199595
Pseudocirrhosis is a diffuse nodularity of the liver that radiologically mimics cirrhosis but is a distinct pathological process. It is seen almost exclusively in patients with liver metastases and may...
5.
Chon U Cheang M, Rimawi M, Johnston S, Jacobs S, Bliss J, Pogue-Geile K, et al.
NPJ Breast Cancer . 2024 Jul; 10(1):54. PMID: 38951507
Intrinsic breast cancer molecular subtyping (IBCMS) provides significant prognostic information for patients with breast cancer and helps determine treatment. This study compared IBCMS methods on various gene-expression platforms in PALOMA-2...
6.
Coriano M, Tommasi C, Dinh A, Needham J, Aziz H, Joharatnam-Hogan N, et al.
Breast Cancer Res Treat . 2024 May; 206(3):603-614. PMID: 38743174
Purpose: Many patients with early breast cancer (eBC) undergoing neoadjuvant chemotherapy do not achieve pathological complete response (pCR), which is a prognostic factor. We examined the role of HER2-low expression...
7.
Freshwater C, Anderson S, Huff D, Smith J, Jackson D, Hendriks B, et al.
Mov Ecol . 2024 Mar; 12(1):21. PMID: 38491373
Background: Ecological and physical conditions vary with depth in aquatic ecosystems, resulting in gradients of habitat suitability. Although variation in vertical distributions among individuals provides evidence of habitat selection, it...
8.
Palmieri C, Linden H, Birrell S, Wheelwright S, Lim E, Schwartzberg L, et al.
Lancet Oncol . 2024 Feb; 25(3):317-325. PMID: 38342115
Background: The androgen receptor is a tumour suppressor in oestrogen receptor-positive breast cancer. The activity and safety of enobosarm, an oral selective androgen receptor modulator, was evaluated in women with...
9.
Rastogi P, OShaughnessy J, Martin M, Boyle F, Cortes J, Rugo H, et al.
J Clin Oncol . 2024 Jan; 42(9):987-993. PMID: 38194616
JCO Two years of adjuvant abemaciclib combined with endocrine therapy (ET) resulted in a significant improvement in invasive disease-free survival (IDFS) and distant relapse-free survival (DRFS) that persisted beyond the...
10.
Timermans A, Otero F, Garrido M, Gosalvez J, Johnston S, Fernandez J
Andrology . 2023 Nov; 12(5):1111-1118. PMID: 37986274
Background: While the kinetics of human sperm nuclear DNA fragmentation (SDF-nDNA) following ejaculation have been described, the dynamics and relationships of mitochondrial DNA copy number per spermatozoon (mtDNAcn) and fragmentation...